Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Cardiovasc. Med., 06 November 2025

Sec. Cardiovascular Epidemiology and Prevention

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1696969

Correction: The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles

  • 1School of Medicine, Universidad Espíritu Santo, Samborondón, Ecuador
  • 2Vicerrectoría de Investigación y Postgrado, Universidad de Los Lagos, Osorno, Chile
  • 3Servicio de Cardiología, Hospital General Universitario Santa Lucía, Cartagena, Spain
  • 4Sociedad Murciana de Hipertensión Arterial y Riesgo Cardiovascular, Cátedra de Riesgo Cardiovascular, Universidad Católica de Murcia, Murcia, Spain

A Correction on

The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles

By López-Gil JF, Abellán-Huerta J and Abellán- Alemán J. (2025). Front. Cardiovasc. Med. 12:1652447. doi: 10.3389/fcvm.2025.1652447

Reference 10 for McEvoy et al. was erroneously written as “McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. (2024) 45(38):3912–4018. doi: 10.1093/eurheartj/ehae178It”.

This reference should be:

“Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. (2025) 152(11). doi: 10.1161/CIR.0000000000001356”.

There were errors in the Description and Mandatory criteria sections of Figure 1.

The text previously read:

Description

• “…analogous to the cumulative effect of the Lilliputians’ rapes.”

Major cardiovascular risk factors

• WC: 90–102♂ cm/80–88♀ cm.

• SBP: 120–139 mm Hg; DBP: 80–89 mm Hg.

• FBG: 100–125 mg/dL.

The corrected text is below:


Description

• “…analogous to the cumulative effect of the Lilliputians’ ropes.”

Mandatory criteria


All 4 must be present:

• WC: 90–101 cm (men)/80–87 cm (women).

• SBP: 120–139 mm Hg and/or DBP: 80–89 mm Hg.

• FPG: 100–125 mg/dL.

There was a mistake in the caption of Figure 1 as published: “FBG, Fasting blood glucose” should be “FPG, Fasting plasma glucose.”


The updated Figure 1 and its caption appear below.

Figure 1
Illustration titled \“Gulliver Syndrome\” showing a man tied down by ropes held by small figures, symbolizing slightly elevated cardiovascular risk factors. Description highlights cumulative risk akin to Lilliputians' ropes. Mandatory criteria include waist circumference, blood pressure, fasting plasma glucose, and non-HDL cholesterol levels. Clinical implications emphasize early intervention for mildly abnormal findings to reduce risk.

Figure 1. Graphical representation of the Gulliver syndrome. A patient's overall cardiovascular risk increases when multiple mildly elevated risk factors coexist. Each rope represents a single, subclinical abnormality (waist circumference, blood pressure, glucose, or non-high-density lipoprotein colesterol) that collectively restrain health, analogous to the ropes of the Lilliputians. DBP, diastolic blood pressure; FPG, Fasting plasma glucose; HDL, high-density lipoprotein; SBP, systolic blood pressure; WC, waist circumference.

A correction has been made to the values and terms in the sections “Proposed definition and diagnostic criteria” and “Case illustration”.

The text previously read:

Proposed definition and diagnostic criteria

- Systolic blood pressure (SBP): 121–139 mmHg and/or diastolic blood pressure (DBP): 81–89 mmHg.

- Fasting plasma glucose (FPG): 101–125 mg/dL.

Case illustration


HDL-C.

The corrected text is below:

Proposed definition and diagnostic criteria

- Systolic blood pressure (SBP): 120–139 mmHg and/or diastolic blood pressure (DBP): 80–89 mmHg.

- Fasting plasma glucose (FPG): 100–125 mg/dL.

Case illustration

- HDL cholesterol.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: obesity, hypertension, diabetes mellitus, cholesterol, biomarkers

Citation: López-Gil JF, Abellán-Huerta J and Abellán-Alemán J (2025) Correction: The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles. Front. Cardiovasc. Med. 12:1696969. doi: 10.3389/fcvm.2025.1696969

Received: 29 September 2025; Accepted: 17 October 2025;
Published: 6 November 2025.

Edited and Reviewed by: Dexter Canoy, Newcastle University, United Kingdom

Copyright: © 2025 López-Gil, Abellán-Huerta and Abellán-Alemán. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: José Francisco López-Gil, am9zZWZyYW5jaXNjb2xvcGV6Z2lsQGdtYWlsLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.